Ifechimere I. Okafor

FDA investigator

Appears on 5 documents from 2024 to 2026, mostly at sites in New York. Most often cites responsibilities of quality control unit (21 CFR 211.22(d)).

5
Documents on file
7.2
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 35 observations

Activity by year

2024: 2, 2025: 1, 2026: 2

Where

New York 3 · Massachusetts 1 · Rhode Island 1

Is Ifechimere I. Okafor coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Perrigo New York, Inc.May 8, 2026 · Bronx, New York
483 Lyne LaboratoriesMar 10, 2026 · Brockton, Massachusetts
483 GC Hanford Manufacturing CompanyMar 20, 2025 · Syracuse, New York
483 Denison Pharmaceuticals, LLCJul 29, 2024 · Lincoln, Rhode Island
483 Equibal IncMay 30, 2024 · Unionville, New York

About this profile

What does Ifechimere I. Okafor inspect?

Ifechimere I. Okafor appears on 5 documents on file covering 5 sites, mostly in New York.

What do they cite most often?

21 CFR 211.22(d) (responsibilities of quality control unit), followed by 21 CFR 211.42(a) and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ifechimere I. Okafor is dated May 8, 2026.